drugs

Roche Enters $1.1B Drug Deal With US's Aileron - Wall Street Journal
Roche Enters $1.1B Drug Deal With US's AileronWall Street JournalVX) Tuesday entered into a partnership deal with US-based biopharmaceutical firm Aileron Therapeutics to produce a novel class of drugs to treat diseases ...Roche signs up to $1.1 billion drug deal with AileronReutersRoche Backs New Method for Drug Delivery to CellsNew York TimesRoche Backs Aileron's Stapled Peptide Technology in $1.1 Billion DealDailyFinanceCanadianBusiness.com�-Xconomyall 59 news articles��

Blog Content